About

About xBiologix xBiologix designs, builds, customizes & validates biomarker profiling products & protocols for solid tissue imaging using our patent pending, click-chemistry reagents & conventional multiplexed immunofluorescent platforms. Our multispectral imaging, antibody-oligo products characterize tumor microenvironments & surrounding tissue with a single incubation of (4-20) primary antibodies & gentle signal removal/re-imaging protocol. This simplified, "one pot" staining protocol is uniquely suited to conventional autostaining & multispectral imaging platforms, & amenable to workflow standardization & validation supporting research & clinical laboratory processes. About xBiologix, Inc. xBiologix designs, builds, customizes & validates biomarker profiling products & protocols for solid tissue imaging using our patent pending, click-chemistry reagents & conventional multiplexed immunofluorescent platforms. Our multispectral imaging, antibody-oligo products characterize tumor microenvironments & surrounding tissue with a single incubation of (4-20) primary antibodies & gentle signal removal/re-imaging protocol. This simplified, "one pot" staining protocol is uniquely suited to conventional autostaining & multispectral imaging platforms, & amenable to workflow standardization & validation supporting research & clinical laboratory processes. xBiologix provides multiplexed, fluorescent microscopy products and service supporting our spatial biology customers. Our ready-to-use, platform independent, pre-validated, massively multiplexed immunofluorescent IHCs (mIHC/IF) protocol radically simplifying the published cyclic protocols— a.k.a cycIF. We seek to partner with small oncology focused drug developers who want to reliably identify potential trial participants by screening patient resected tumors for the candidate's mode of action.